Long-Term Active Surveillance of Screening Detected Subsolid Nodules is a Safe Strategy to Reduce Overtreatment

Journal of Thoracic Oncology

Volumn 13, Issue 10, 2018, Pages 1454-1463

  Silva, Mario ^a,b   Prokop, Mathias ^c   Jacobs, Colin ^c   Capretti, Giovanni ^a   Sverzellati, Nicola ^a   Ciompi, Francesco ^c   van Ginneken, Bram ^c   Schaefer Prokop, Cornelia M ^c,d   Galeone, Carlotta ^e   Marchianò, Alfonso ^b   Pastorino, Ugo ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MEANDER MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Cause of death; Conservative management; Early diagnosis; Lung cancer; Overdiagnosis; Subsolid nodules

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; COHORT ANALYSIS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE GUIDED BIOPSY; INCIDENCE; LARGE CELL CARCINOMA; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; PATIENT SAFETY; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; SEGMENTECTOMY; SMOKING HABIT; SQUAMOUS CELL CARCINOMA; SUBSOLID NODULE; TRANSTHORACIC BIOPSY; CLINICAL TRIAL; EARLY CANCER DIAGNOSIS; HEALTH SERVICE; MASS SCREENING; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; SURVIVAL ANALYSIS;

EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MASS SCREENING; MEDICAL OVERUSE; MIDDLE AGED; SOLITARY PULMONARY NODULE; SURVIVAL ANALYSIS;

EID: 85056383368     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/j.jtho.2018.06.013     Document Type: Article

References (49)

1. National Lung Screening Trial Research Team, Aberle, D.R., Adams, A.M., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365 (2011), 395–409.
2. Esserman, L.J., Thompson, I.M. Jr., Reid, B., Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA 310 (2013), 797–798.
3. Patz, E.F. Jr., Pinsky, P., Gatsonis, C., et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 174 (2014), 269–274.
4. Bach, P.B., Overdiagnosis in lung cancer: different perspectives, definitions, implications. Thorax 63 (2008), 298–300.
5. Carter, J.L., Coletti, R.J., Harris, R.P., Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. BMJ, 350, 2015, g7773.
6. Kakinuma, R., Noguchi, M., Ashizawa, K., et al. Natural history of pulmonary subsolid nodules: a prospective multicenter study. J Thorac Oncol 11 (2016), 1012–1028.
7. Travis, W.D., Asamura, H., Bankier, A.A., et al. The IASLC Lung Cancer Staging Project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM Classification of Lung Cancer. J Thorac Oncol 11 (2016), 1204–1223.
8. Yip, R., Wolf, A., Tam, K., et al. Outcomes of lung cancers manifesting as nonsolid nodules. Lung Cancer 97 (2016), 35–42.
9. Revel, M.P., Mannes, I., Benzakoun, J., et al. Subsolid lung nodule classification: a CT criterion for improving interobserver agreement. Radiology 286 (2018), 316–325.
10. Heidinger, B.H., Anderson, K.R., Nemec, U., et al. Lung adenocarcinoma manifesting as pure ground-glass nodules: correlating CT size, volume, density, and roundness with histopathologic invasion and size. J Thorac Oncol 12 (2017), 1288–1298.
11. Scholten, E.T., Horeweg, N., de Koning, H.J., et al. Computed tomographic characteristics of interval and post screen carcinomas in lung cancer screening. Eur Radiol 25 (2015), 81–88.
12. Lung-RADS Version 1.0 Assessment Categories. April 28, 2014. http://www.acr.org/∼/media/ACR/Documents/PDF/QualitySafety/Resources/LungRADS/AssessmentCategories. Accessed January 1 2017.
13. Pinsky, P.F., Gierada, D.S., Black, W., et al. Performance of lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med 162 (2015), 485–491.
14. National Comprehensive Cancer Network Guidelines, Version 3.2018, Lung Cancer Screening. https://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdf. Accessed March 19, 2018.
15. Kotwal, A.A., Schonberg, M.A., Cancer screening in the elderly: a review of breast, colorectal, lung, and prostate cancer screening. Cancer J 23 (2017), 246–253.
16. Flores, R., Taioli, E., Yankelevitz, D.F., et al. Initiative for early lung cancer research on treatment: development of study design and pilot implementation. J Thorac Oncol 13 (2018), 946–957.
17. Bach, P.B., Mirkin, J.N., Oliver, T.K., et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 307 (2012), 2418–2429.
18. Leduc, C., Antoni, D., Charloux, A., et al. Comorbidities in the management of patients with lung cancer. Eur Respir J, 49, 2017, 1601721.
19. Silva, M., Sverzellati, N., Manna, C., et al. Long-term surveillance of ground-glass nodules: evidence from the MILD trial. J Thorac Oncol 7 (2012), 1541–1546.
20. Sverzellati, N., Silva, M., Calareso, G., et al. Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen. Eur Radiol 26 (2016), 3821–3829.
21. Jacobs, C., van Rikxoort, E.M., Twellmann, T., et al. Automatic detection of subsolid pulmonary nodules in thoracic computed tomography images. Med Image Anal 18 (2014), 374–384.
22. Charbonnier, J.P., Chung, K., Scholten, E.T., et al. Automatic segmentation of the solid core and enclosed vessels in subsolid pulmonary nodules. Sci Rep, 8, 2018, 646.
23. Horeweg, N., Scholten, E.T., de Jong, P.A., et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 15 (2014), 1342–1350.
24. Detterbeck, F.C., Chansky, K., Groome, P., et al. The IASLC Lung Cancer Staging Project: methodology and validation used in the development of proposals for revision of the stage classification of NSCLC in the forthcoming (eighth) edition of the TNM Classification of Lung Cancer. J Thorac Oncol 11 (2016), 1433–1446.
25. Xie, J., Liu, C., Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Stat Med 24 (2005), 3089–3110.
26. Walter, L.C., Covinsky, K.E., Cancer screening in elderly patients: a framework for individualized decision making. JAMA 285 (2001), 2750–2756.
27. Yousaf-Khan, U., van der Aalst, C., de Jong, P.A., et al. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval. Thorax 72 (2016), 48–56.
28. Silva, M., Galeone, C., Sverzellati, N., et al. Screening with low-dose computed tomography does not improve survival of small cell lung cancer. J Thorac Oncol 11 (2016), 187–193.
29. Gierada, D.S., Pinsky, P.F., Duan, F., et al. Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants. Eur Radiol 27 (2017), 3249–3256.
30. Yankelevitz, D.F., Yip, R., Smith, J.P., et al. CT screening for lung cancer: nonsolid nodules in baseline and annual repeat rounds. Radiology 277 (2015), 555–564.
31. Scholten, E.T., de Jong, P.A., de Hoop, B., et al. Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules?. Eur Respir J 45 (2015), 765–773.
32. Yip, R., Henschke, C.I., Xu, D.M., et al. Lung cancers manifesting as part-solid nodules in the National Lung Screening Trial. AJR Am J Roentgenol, 2017, 1–11.
33. Vazquez, M., Carter, D., Brambilla, E., et al. Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer 64 (2009), 148–154.
34. Leventakos, K., Peikert, T., Midthun, D.E., et al. Management of multifocal lung cancer: results of a survey. J Thorac Oncol 12 (2017), 1398–1402.
35. Yip, R., Li, K., Liu, L., et al. Controversies on lung cancers manifesting as part-solid nodules. Eur Radiol 28 (2018), 747–759.
36. Henschke, C.I., Salvatore, M., Cham, M., et al. Baseline and annual repeat rounds of screening: implications for optimal regimens of screening. Eur Radiol 28a (2018), 1085–1094.
37. Etzioni, R., Gulati, R., Recognizing the limitations of cancer overdiagnosis studies: a first step towards overcoming them. J Natl Cancer Inst, 108, 2015 piidjv345.
38. Thakur, M.K., Ruterbusch, J.J., Schwartz, A.G., et al. Risk of second lung cancer in patients with previously treated lung cancer: analysis of Surveillance, Epidemiology, and End Results (SEER) Data. J Thorac Oncol 13 (2018), 46–53.
39. Henschke, C.I., Yip, R., Smith, J.P., et al. CT screening for lung cancer: part-solid nodules in baseline and annual repeat rounds. AJR Am J Roentgenol 207 (2016), 1176–1184.
40. Sarna, L., Evangelista, L., Tashkin, D., et al. Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer. Chest 125 (2004), 439–445.
41. Falcoz, P.E., Conti, M., Brouchet, L., et al. The Thoracic Surgery Scoring System (Thoracoscore): risk model for in-hospital death in 15,183 patients requiring thoracic surgery. J Thorac Cardiovasc Surg 133 (2007), 325–332.
42. Feinstein, M.B., Krebs, P., Coups, E.J., et al. Current dyspnea among long-term survivors of early-stage non-small cell lung cancer. J Thorac Oncol 5 (2010), 1221–1226.
43. Schreuder, A., Schaefer-Prokop, C.M., Scholten, E.T., et al. Lung cancer risk to personalise annual and biennial follow-up computed tomography screening. Thorax 73 (2018), 626–633.
44. Kravchenko, J., Berry, M., Arbeev, K., et al. Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis. Lung Cancer 88 (2015), 85–93.
45. Sverzellati, N., Cademartiri, F., Bravi, F., et al. Relationship and prognostic value of modified coronary artery calcium score, FEV1, and emphysema in lung cancer screening population: the MILD trial. Radiology 262 (2012), 460–467.
46. Wille, M.M., Dirksen, A., Ashraf, H., et al. Results of the randomized Danish lung cancer screening trial with focus on high-risk profiling. Am J Respir Crit Care Med 193 (2016), 542–551.
47. Zhao, Y., de Bock, G.H., Vliegenthart, R., et al. Performance of computer-aided detection of pulmonary nodules in low-dose CT: comparison with double reading by nodule volume. Eur Radiol 22 (2012), 2076–2084.
48. Rubin, G.D., Roos, J.E., Tall, M., et al. Characterizing search, recognition, and decision in the detection of lung nodules on CT scans: elucidation with eye tracking. Radiology 274 (2015), 276–286.
49. Liang, M., Tang, W., Xu, D.M., et al. Low-dose CT screening for lung cancer: computer-aided detection of missed lung cancers. Radiology 281 (2016), 279–288.